Cumulatively, our results indicated that FoxM1 silencing in resistant HCC cells effectively sensitized them to the tumor suppressive activities of Artemisinin, reflected by their attenuated neoplastic transformations and enhanced apoptosis. Here, FOXM1 is linked to hepatocellular carcinoma.